Disclaimer: The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of Dune Medical.
Emerging Technologies Impacting Cancer Care: How Dune Medical is Helping Surgeons Identify Additional Cancer in the Operating Room
MarginProbe® recognized as a noteworthy medical device for helping reduce positive margins for lumpectomy surgeries by Tim Clay during an interview for News Medical Life Sciences.
MarginProbe® Shrinks Positive Margin Rates and Tissue Volume Removed for Both Invasive and DCIS Breast Cancers
Dr. Reid is a firm believer in the success of MarginProbe in improving the results of breast cancer surgery.